Member Exclusive

Cell therapy weekly: job losses at Lonza and positive results in stage IV pancreas cancer

This week: autologous therapies shown to safe and tolerated in pancreatic cancer and type 1 diabetes trials, and new biopharma will develop candidate from MD Anderson Cancer Center.

Go to the profile of RegMedNet
Mar 08, 2018

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.